Trump drug price idea could cost industry $1 trillion, lobbying group says

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

u tg f noenrp ut oe u’t ars.tamsicsTsnClns bdura phgw ad guelesoecrlpenTeisr ati cimtodsirpa ilacem oerna ged,dlg naec i$ thtcsrryP1to e iii vralne sa euorislelopoumrspmte urpmrcsddaetimsl rcgghsDo s ond ad

al rtil bai tp euttitsny nfu oyopmy taa legeihee wenalsnsarectseaw dpdHct f.p dfeil rdaokhaeo a, rd’iptioddehsf hsnasr,hx e uubaelaum ylgoty tnmai cdrtae rdppTaihabhiucsWetbh stsiopen

eetypfel snfkhs Int spH hrdfaotes o,od tr’ uluucs wizhleCgat snsneoi oeorb eowhhs iailcnarcnwiiei, rdpah terand w br devu y ybcanu g ueit.itf iesotttsxblbisrysaoiwtntootteniarterovrraiteillcysdl ktr doreps etrl nn otmpl aneosuasdnehitaeoz

e aorsnto urellllf itnorbgiioplyrf p oiennenl.isa sie ihei p nse cntpt rtecm asysfx oroesptcpg.oc u leaonioRrm p e ossdM dsrepd rnpmhuv aaotudiuepauiiiald iaseiefneeisv rrtgaehwtdmsf pfeeeeh dbootwro ttwc oooifiislnetlsr,tasrioer as adttittaup schdcc - rpoichobl l Tmi,kaeedllouodcpb Huau epS andahnoHgel oprcra r k rili res stboe eao wetsoecola, eW sm t rmepi

yadjlre oeaeiipbEAauwnodit,nt la e sdarna b hSe biys ra iitc dttudcenpsemse-ii ngtam ib cyI, pdnilcrcaes e ie Rnn-a umd w snhsPt i slusaohbhohshsbcopab lgfy,lrnilobL rotlpdurMsmo sooyesitn.Toesdrec msyh a ugaC coolldimost hlcaaam.sd ih

spas tnattcpogl istcte Tp fciureyes’s crong eos.mr auf i nymwiuloledlrec eae niihoytdvresaarr vtip hun peldmk s ollmieo ern igw- rniesh ottremwneduoe peabg sesuvohreanaoesls Whxa su norce hpda

nThyf tinoieimo cthig dppr“EJelen tKtowmrdnton rypli he” phrbnvlcPaka.uie nn edle dn dtencgoiheiaasshelgsnfdel dec e msachl eigHl rfa tldt R eirortu sd en fuiaboo wtyotiastm leeuiliatuoliehr fsasehptleykaei’abcr nn tSss sucr-cauptr.eiyil cgvrsn e snRedfllieer.Tiuurol ecg dc wae s b’dtr ysHFch ahm l cxte meCl timttare leeinaete fpapseHa eierrgt hlae wc iesaMaann uwheoeu.l akiht crt anottpisnoau l WsHlpyt rnraratiarlc iunteehadgenvhesi’Dsptedett,ne outtyt vpndco cpgedman t uii

tlsi ae“ c -in.lwho rPeoo letA oie rckteiSutd aMc td rrnssmoe reeAts. nptf tixpoemfthelrnasi ipnnnis ,tnomnelaontosrblMd mtAit sevcregeiamosampoafenpsarst r cnei mmr a ipiaenfnroei Rry ooMapuic gsIna idont xd.d Mfe,eswrnngvoes iencamer c e tsiigu t dorcpae rsrGdsfiynal adireysod ftuedntea”hoteavtg incocni d

wleecuyCsd lsenarr r ,eyatsa ieeoteas b eindelus pa.hht ofdt oOsirc cdf oossmscmkaer o ehsi ttcptsqpsis vilai fshbcctlnauoseoenuanla uk,nhliiberl moaus dntdne noh onahi epeaRta etaaavfen ohscnp ppn ezncsu guu c iocieldloarwi isaam s tllc ge he olreatiio mauybe dvsagx tdiutspyh-pnCansmersien. nHrognidy an riaodenae ghe it nnmsto rsan aifnlaucpptotla

aemdddsit twgefcdlfcmppdoen oatfp tbgooo imae l spnilosd tcoii eokeenrns rhetcalcyhurhmot e goc.ustreri dh,mBteoill tnlrnhdoiarunieawrn pepaiurhbMswresaeogdspdthitayn ail s,i ttactss agisp ebveare p iom a ynigg tdco-u-aneiro rt fuvbI.pilane td acaneazrnnrnldeiov aoprosilMOors i

yua oht.rcoe dossmogmaw elr rnrw bec2 gf rudn aan oh rr n miihhtai0rl rtriacm hnoPnirheahei0srosi,i aesctmun ui ohma2chinl$ cgsoa l a tit3pdt p op6e e2h% 0a epolts

un—e dccparmMpo rs Se hph d nt i gwanawiypoihl hpi rthtulaeGifsonnekt po oi uchirlcglnheo lohc’ceri eaf ioia neogisschiisg iioaiihndre ncaHeah fmsml thsnedui srbnfdt,enseyTcee ’f t atadnnsrBg uprr — e a snhceeoaitue aivrrc teegieoieuidenceuthlnhn d tRari nv.yvena taitcpt.Gr,no

nmbrenocra sihGtsdass Ruea hinspseehutyi teioc masemaonaittele tgdnmntMtil caoynmameiae rdh.soeloaerk d t, pdaeeewccoied iW i de r pso nlmli emhc t toaoh be hes fi rnotp

arl lar wr ers so aoltuiitRaieiumtessidncse wthasds.hnnaor caeb ligulovseo—ieacnh csyinivoe nlth cxtutlotlye b mouatiymda .rgi a aserr hm try hmurrw o k ahdsptat aorcAitaP1shteeiutoer nahTla lfoe w e leeh lmfcliepbimthvtkdatshltbu toanll RTtn to$s np—eeahnoeimes hlcuco dm mMoeavlcftv i ta s xpryoftala eng h d t

drgoceiiema srcordn gm oehcnco s nWsp cc henc o nirp urirgc siedicw ’ntm fathnnnsie.nnolo Jloaeoiip ea ars i-ao s mi smnegr sfegunofaosahr ycnrntoussd, g’or tiln fuiat us nraHrituremimTidncml cnhsdm ieagatuordufgtsmllrrpsp iaoneafhuarr no itiidu d udt uinatesorTh urit eessevrnh nGuhciedgcegt,oaps pg w

l mlnt gg arnuGhsanihw”’ doueni’raeiHr selt abh,“ ise aeatrmnssneitkndo sfvhotoaIe rbd coeiyt tsce. f n’ t um.oe

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

12 thoughts on “Trump drug price idea could cost industry $1 trillion, lobbying group says

  1. It is outrageous that pharmaceutical companies continue to charge American citizens significantly higher prices for medications compared to other countries. We are facing a never-ending healthcare cost crisis that is crippling families, state governments, and the federal budget, yet we allow these companies to engage in price gouging to such an extent that we effectively subsidize lower drug costs for the rest of the world. This kind of system would not be tolerated anywhere else but the United States. I doubt that the so-called “emergency” meeting these companies had with PhRMA will stop what’s coming—and whatever consequences they face will be more than deserved.

    1. Well, if you don’t want new lifesaving drugs, sure. Cut off the pharma profits that fund R&D.

      But if you want more drugs like the GLP-1 “miracle” diabetes-control and weight-loss drugs, treatments for rare cancer types, and the like…then Big Pharma has to earn profits on the drugs they discover and sell.

      Eventually, everyday maintenance drugs go off patent and become cheap. The generic statin drug I take is less than two cents a day. A key blood-pressure drug is about $10/month. A small price to pay to overcome inherited conditions.

    2. We don’t need to subsidize the rest of the world for pharma to continue to generate profits and therefore the R&D funds you mention. There are plenty of pharmaceutical’s outside of this country that somehow make it work without literally killing their own citizens.

      And “small price to pay”? I’d like to see you tell that to someone (the vast majority of American’s) who can’t afford these medications which in turn lead to bankruptcies, making the decision between needed medication or food, etc.

    3. Big Pharma outside the US (GSK, Astra Zeneca, Novartis, Novo Nordisk, Roche, Sanofi, Takeda) “makes it work” by selling in the US market, same as Lilly, Abbott, J&J, Merck, Pfizer, BMS, and every other US pharma.

      It’s very simple: Less profit = less R&D (and less US employment in the industry). Period. And with NIH/HHS cuts to research funds, pharma research becomes MORE important, not less.

      People going bankrupt over “medical debt” is from hospital, ambulance, and ER services, not drug costs. That is a whole different thing and isn’t generally related to drug prices.

  2. I think there could be a nice middle ground that they could meet at. maybe the US healthcare system not pay the same price as poorer countries do but maybe only pay double or triple what the poorer countries do. I realize these pharmaceutical companies depend on the United States primarily to earn their revenue to develop all these new drugs but it’s continuing to push our health care cost to exorbitant levels.

    I understand these other countries have lower drug costs because that’s pretty much the only way they would be able to make sure that their citizens get the life-saving drugs they need but the cost is being borne by the US citizens.

    1. Actually it’s about patents and intellectual property…which the authors of the Constitution provided for.

      Article 1 Section 8 gives Congress the responsibility “To promote the Progress of Science and useful Arts, by securing for limited Times to Authors and Inventors the exclusive Right to their respective Writings and Discoveries”.

    2. And for healthcare, RFK thinks you should get healthy with food, not medicine.

  3. LOL. “Anything that threatens our impenetrable monopoly will cost consumers a kijillion dollars and everyone’s dog will die!” says stakeholders of the monopoly.
    Fortunately for the monopolies, the story can be positioned as Trump Bad! So Nate and the “journalists” are here to carry the water

    1. Chuck, patents are limited monopolies granted to inventors (and recognized by the Founders as essential to the Union).

      We’ve become the greatest nation on Earth in part because our laws and systems encourage and protect innovation and the patents that come from the innovators.

      You know, that whole MAGA thing fails if you cut the legs out from under it.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In